Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-density lipoprotein revisited: biological functions and clinical relevance. | Eur Heart J | 2023 | 36337032 | PubTator, text mining | PubMed |
| Comparison between renal pelvic and ureteral tumors in muscle-invasive upper tract urothelial carcinoma. | Cancer Sci | 2023 | 36330561 | PubTator, text mining | PubMed |
Up-regulation of oxidized low-density lipoprotein receptor 1 correlates with decreased miR-106b-5p, miR-93-5p, miR-3129-5p, miR-199b-3p, and miR-4465, higher recurrence rate, and poor prognosis in ovarian cancer. | Histol Histopathol | 2023 | 36264049 | PubTator, text mining | PubMed |
| Circulatory soluble LOX-1 is a novel predictor for coronary artery disease patients. | Cardiovasc J Afr | 2023 | 36218037 | PubTator, text mining | PubMed |
| Early Mid-pregnancy Blood-Based Proteins as Possible Biomarkers of Increased Infant Birth Size in Sex-Stratified Analyses. | Reprod Sci | 2023 | 36180668 | PubTator, text mining | PubMed |
| Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapy. | Semin Immunopathol | 2023 | 36161514 | PubTator, text mining | PubMed |
| Tonsillar transcriptional profiles in atopic and non-atopic subjects. | Allergy | 2023 | 35899482 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and survival analysis for oral squamous cell carcinoma: A transcriptomic study. | Oral Dis | 2023 | 35796645 | PubTator, text mining | PubMed |
| Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease. | Chronobiol Int | 2023 | 35758140 | PubTator, text mining | PubMed |
| Amelioration of C-Reactive Protein and Lectin Like Oxidized Low Density Lipoprotein Receptor Complex Induced Endothelial Dysfunction by Oligomeric Proanthocyanidins. | Appl Biochem Biotechnol | 2023 | 35357665 | PubTator, text mining | PubMed |
| Impact of oxidized LDL/LOX-1 system on ligamentum flavum hypertrophy. | J Orthop Sci | 2023 | 35123844 | PubTator, text mining | PubMed |
| A Comprehensive Review on PCSK9 as Mechanistic Target Approach in Cancer Therapy. | Mini Rev Med Chem | 2023 | 34856898 | PubTator, text mining | PubMed |
| Proteomics research of SARS-CoV-2 and COVID-19 disease. | Med Rev (2021) | 2022 | 37724330 | PubTator, text mining | PubMed |
| CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. | Nat Aging | 2022 | 37118088 | PubTator, text mining | PubMed |
| Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 acts as a new biomarker for NSTEMI and STEMI patients. | Afr Health Sci | 2022 | 36910399 | PubTator, text mining | PubMed |
| Advancements in nanomedicines for the detection and treatment of diabetic kidney disease. | Biomater Biosyst | 2022 | 36824160 | PubTator, text mining | PubMed |
| Single-cell analysis of myeloid cells in HPV+ tonsillar cancer. | Front Immunol | 2022 | 36741389 | PubTator, text mining | PubMed |
| Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma. | Front Oncol | 2022 | 36733370 | PubTator, text mining | PubMed |
| Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma. | Front Oncol | 2022 | 36727080 | PubTator, text mining | PubMed |
| Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis. | Front Cardiovasc Med | 2022 | 36727024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=37